This week’s Lancet Journal (from England) has an important study supporting the use of aspirin in preventing colon cancer.
Aspirin at 600mg daily (equivalent of 2 full dose pills) yielded a significant reduction in colon cancers in patients with Lynch Syndrome (a genetic predisposition to colon cancer). Although not clearly applicable to other patients with polyps or sporadic cases of colon cancer, it is good evidence to support the possibility that such patients would benefit.
Combining the heart and stroke prevention abilities of aspirin with the colon cancer data provides more support for use of aspirin as a general preventive in adults.